Welcome to our subcommittee.
I'm Joy Smith, the chair of the subcommittee.
It does feel like a full-fledged committee. We've done so much work on neurological disorders , and it's been a very serious topic with the members of the subcommittee.
This morning, pursuant to Standing Order 108(2), we are continuing our study on neurological disorders.
We are going to be starting with individuals. We have Dr. Song, from the Canada Research Chair in Alzheimer's Disease. We have Dr. Serge Gauthier. From the Canadian Institutes of Health Research, we have Dr. Rémi Quirion, executive director. From Canada's Research-Based Pharmaceutical Companies, we have Mark Ferdinand, vice-president of policy. From NeuroScience Canada, we have Inez Jabalpurwala, president.
Welcome to all of you.
We will start with you, Dr. Song. You have five minutes for your presentation.